ASCO 2025: Advancing lung cancer research through Real-World Data and radiomics
From AI-powered RWD to secure data environments, BC Platforms’ ASCO 2025 abstracts highlight the next frontier in lung cancer research.
1
min read
EHDS: uniform access to European healthcare data for research and AI
-
Copy link - Send email
- Share on Facebook
- Share on Twitter
Executive summary
Presented at BIO-Europe 2024 in Stockholm, this abstract by Timo Kanninen, our Chief Science Officer, explores how the European Health Data Space (EHDS) will transform healthcare data access across Europe. It highlights how automation, interoperability, and GDPR-compliant frameworks are paving the way for secure, cross-border research and AI innovation.
Continue reading
Read more
Relevance and specificity of the CIAN Lung cohort for clinical research analyses in cancer
The CIAN LUNG cohort is a multicentric initiative using clinical, imaging, and biomarker data to generate Real-World Evidence and advance lung cancer research.
Methodology for estimation of progression-free survival in patients with NSCLC
A new methodology from the CIAN LUNG cohort demonstrates how real-world data can be used to estimate progression-free survival in non-small cell lung cancer.